Reporting on Adverse Clinical Events, 2019

DOI: 10.1177/0069477019852683

Keywords: 1,1-Difluoroethane (130),Acetaminophen (137),Buprenorphine (136),Carfentanil (141),Chlorpromazine (133),Cocaine (131),Dabigatran (139),Eszopiclone (135),Losartan (142),Nivolumab (132),Olanzapine (133),Psychostimulants (131),Risperidone (138),Sulfamethoxazole (140),Tacrolimus (134),Zaleplon (135),Zolpidem (135)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text